Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Botulinum toxin: clinical use.

Daniel D Truong1, Wolfgang H Jost

  • 1The Parkinson's and Movement Disorder Institute, 9940 Talbert Avenue, Fountain Valley, CA 92708, USA. dtruong@pmdi.org

Parkinsonism & Related Disorders
|July 28, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Consensus Guidelines for Therapeutic Drug Monitoring in Neuropsychopharmacology: Update 2026 - Pharmacokinetic, pharmacogenetic and clinical aspects.

Pharmacopsychiatry·2026
Same author

The German Parkinson expert meetings.

Journal of neural transmission (Vienna, Austria : 1996)·2026
Same author

Editorial: Cognition in Parkinson's disease.

Frontiers in cognition·2026
Same author

Beyond "Advanced": proposing Fluctuation-Dominant Parkinson's disease as a functional alternative to enable timely device-aided therapy.

Journal of neural transmission (Vienna, Austria : 1996)·2026
Same author

Real-World Safety and Effectiveness of 24-Hour Foslevodopa/Foscarbidopa in Parkinson's Disease: ROSSINI Study 6-Month Interim Results.

Neurology and therapy·2026
Same author

Are We Heading into a Dead End, or Are We Treading Water?

Toxins·2026
Same journal

Adverse event trajectories and treatment discontinuation in advanced Parkinson's disease treated with levodopa/carbidopa intestinal gel.

Parkinsonism & related disorders·2026
Same journal

GBA1 variants and dopaminergic imaging in essential tremor with atypical features: A comparative study with Parkinson's disease.

Parkinsonism & related disorders·2026
Same journal

Cerebellum crus II cortical thickness as a cognitive brain reserve in Parkinson's disease.

Parkinsonism & related disorders·2026
Same journal

Serious games and virtual reality in Parkinson's disease rehabilitation: A systematic review of randomized controlled trials.

Parkinsonism & related disorders·2026
Same journal

Respiratory-swallow training in Parkinson's disease: Effects of a single session on swallowing safety and efficiency with exploratory comparisons of biofeedback.

Parkinsonism & related disorders·2026
Same journal

Levodopa responsive childhood-onset generalized dystonia with diaphragmatic involvement associated with an SPTBN2 variant.

Parkinsonism & related disorders·2026
See all related articles

Botulinum neurotoxin (BoNT) is a versatile drug used for over 25 years in medicine and cosmetic applications. This review covers its established and emerging clinical uses, including neurological and aesthetic treatments.

Area of Science:

  • Neurology
  • Ophthalmology
  • Cosmetic Medicine

Background:

  • Botulinum neurotoxin (BoNT) was initially developed for blepharospasm and strabismus over 2.5 decades ago.
  • It has since become a standard treatment for various medical conditions.
  • BoNT also has significant applications in cosmetic procedures.

Purpose of the Study:

  • To provide an extensive review of the current and potential clinical applications of botulinum neurotoxin.
  • To highlight the versatility and expanding role of BoNT in different medical fields.

Main Methods:

  • Literature review of clinical applications of botulinum neurotoxin.
  • Synthesis of data on established, standard-of-care, and investigational uses.

Main Results:

Related Experiment Videos

  • BoNT is the standard of care for cervical dystonia, hemifacial spasm, focal spasticity, hyperhidrosis, and ophthalmological/otolaryngeal disorders.
  • Established cosmetic applications.
  • Investigational uses include gastroenterologic and urologic indications, pain management, and migraine.

Conclusions:

  • Botulinum neurotoxin is a highly versatile therapeutic agent with a broad spectrum of clinical applications.
  • Its use extends beyond initial indications to encompass numerous medical and cosmetic fields.
  • Ongoing research continues to uncover new therapeutic possibilities for BoNT.